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Pathological changes in the spine are often accompanied by pain syndrome at a young age. 
However, the significance of comorbid disorders in the formation and course of vertebrogenic 
pain syndrome has not been studied enough.The objective of the article to clarify the role of 
comorbid disorders in young adults with unclassified dysplastic phenotype in the formation 
of vertebrogenic pain syndrome. 61 male patients from 18 to 26 years old with pain syndrome 
in the spine were examined. Depending on the presence of signs of a dysplastic phenotype 
the patients were divided into two groups. The first group included 28 patients (median age 
22 (21; 23) years), the second group consisted of 33 people (median age 23 (19; 24) years). All 
patients underwent a comprehensive examination, including neurological and somatic exami-
nation, neuroradiological, ultrasound and psychological methods of investigation, also took 
into account clinical and anamnestic data. Pain syndrome, the state of the autonomic nervous 
system and the presence of signs of a dysplastic phenotype were assessed using scales and 
indices. Statistical data processing was performed using the STATISTICA 10.0 program. Dif- 
ferences were considered statistically significant when p < 0.05. According to neuroimag-
ing data, signs of widespread dysplastic and more pronounced scoliotic and kyphoscoliotic 
changes of the spine, vertebral anomalies, segmental instability were authentically more fre-
quent in patients with the unclassified connective tissue dysplasia phenotype (p<0,05). They 
had more severe vertebrogenic pain syndrome, which was more intense and long-lasting and 
was on the background of a greater neurological deficit with autonomic lability and psycho-
pathological disorders, headaches, somatic dysfunction with a prevalence of diseases of the 
bronchopulmonary system and ENT organs in the control group (p<0.05). Research findings 
allow us to consider the prevalence of pathological changes in the spine, depressive disorders, 
somatic and cerebral burden as factors contributing to the formation of pain syndrome in 
patients with vertebrogenic pathology and connective tissue insufficiency.
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Introduction
Spinal pain is the second most frequent medical condition in the world and repre-
sents a serious socioeconomic problem, as it is most common among the working-age 
population [1]. Recently, there has been an increase in the prevalence of spinal diseases 
among young people [2; 3]. At the same time, they often have signs of connective tissue 
dysplasia with multiple organ involvement, which may influence the course of pain syn-
drome [4; 5]. The most widespread are undifferentiated forms of connective tissue dyspla-
sia (UCTD). Young people with increased dysplastic stigmatization according to UCTD 
make up from 20 % to 80 % among young people [6–8]. Dysplastic-associated diseases 
usually have a progressive course, and the spinal column undergoes regular degenerative 
changes [9; 10]. Investigating the role of comorbid diseases in the course of pain syndrome 
in young adults with vertebrogenic pathology will provide a systematic approach to the 
treatment of this category of patients. This has both practical and theoretical significance 
[11; 12]. The study aimed to clarify the role of comorbid disorders in young people with 
an unclassified dysplastic phenotype in the formation of vertebrogenic pain syndrome.
Materials and methods
The study involved 61 male patients with pain in the cervical, thoracic and/or lum-
bar spine. The main (1) group included 28 patients with signs of a dysplastic phenotype 
(median age 22  (21; 23)  years). The control (2)  group consisted of 33  people (median 
age 23  (19; 24)  years). All patients underwent a comprehensive examination, includ-
ing clinical and anamnestic diagnostic methods, including the collection of anamnesis 
about already identified functional disorders, morphological features, diseases that could 
be markers of CTD; neurological and physical examination; neuroradiological (X-ray, 
MRI, CT of different parts of the spine, head); ultrasound (echocardiographic and dop-
pler evaluation of brachiocephalic vessels — according to indications), consultations of 
specialists — orthopedist, therapist, ophthalmologist, psychologist — according to indi-
cations and psychological research methods. The pain intensity was assessed using the 
Visual Analogue Scale (VAS) and psychological testing for the presence and severity of 
depression was performed using the Beck Scale. To assess the involvement of connective 
tissue in the pathological process, the sum of the diagnostic coefficients of the signs of 
connective tissue dysplasia was calculated based on Wald’s sequential analysis as modified 
by Genkin A. A. (2018) [13]. Statistical data processing was performed using the STATIS-
TICA 10.0 program (TIBCO Software Inc.). Methods of nonparametric and parametric 
statistics were used (Mann — Whitney U-test, Fisher’s exact test, Pearson’s χ2 test, χ2 test 
with Yates’ correction, Pearson correlation test).
Data in the text and tables are presented as median, upper and lower quartiles (Me 
[LQ; UQ]). Differences were considered statistically significant at p < 0.05.
Results
According to the data of neuroradiological examination, it was revealed that dege- 
nerative-dystrophic changes in the spine dominated in patients of both groups. In group 
1  patients signs of a widespread dysplastic and degenerative-dystrophic process, more 
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pronounced scoliotic and kyphoscoliotic changes in the spine, anomalies, segmental in-
stability and retrolisthesis were significantly more frequent (p < 0.05) (Fig. 1).
The main group was dominated by widespread pain in 3 parts of the spine; in the 
control group, pain localized in one part of the spine was more common (p<0.05), Table 1.
Table 1. Patient distribution depending on pain prevalence
Pain 1 group (n = 28) 2 group (n = 33) p (1–2)
in 1 part of the spine 2 (7,1 %) 19 (57,6 %) p<0,05
in 2 part of the spine 12 (42,9 %) 10 (30,3 %) p>0,05
in 3 part of the spine 14 (50 %) 4 (12,1 %) p<0,05
Note: p — significance of differences between groups; Group 1 — patients with connective tissue dys-
plasia phenotype; 2 — control group.
Pain syndrome in patients with connective tissue insufficiency phenotype lasted for 
a longer time than in patients of the control group (medians are 4.5 (4.0; 5.0) and 2.0 (2.0; 
3.0) years), and was more intense (medians are 5.0 (4.0; 5.0) and 4.0 (3.0; 4.0) points), 
Fig. 1. Distribution of patients depending on the frequency of structural pathology of the 
spine according to neuroradiological research
Note: *  — significance of differences between groups when p < 0.05; DDD  — Degenerative disc 
disease; WDDCSMS — widespread (in 3 regions of spine) dysplastic and degenerative changes in spinal 
motion segments; S1 — first degree of scoliosis according to the Chaklin’s classification (Cobb angle is 1°–
10°); S2 — second degree of scoliosis according to the Chaklin’s classification (Cobb angle is 11°–25°); KS — 
kyphoscoliosis; SDH — Spinal disc herniation; CJA — Craniovertebral junction anomalies; VA — Vertebral 
anomalies; RL — Retrolisthesis; SI — Segmental instability; CShD — the consequences of Scheuermann’s 
disease; CVCF — consequences of vertebral compression fracture; VH — Vertebral hemangiomas.
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p < 0.05. At the same time, in patients of the main group with widespread lesions of the 
spine (within 3 parts of the spine), higher pain indices were determined according to the 
VAS than in patients with pathological changes within one or two parts of the spinal col-
umn (p < 0.05) (Fig. 2).
Pain syndromes were accompanied by changes in the psychoemotional sphere. 
Psychopathological disorders in patients occurred mainly in the form of neurotic dis-
orders — asthenic syndrome, anxiety-phobic and obsessive-compulsive disorders. De-
pressive disorders assessed on the Beck Scale were encountered in varying degrees of 
severity. In patients of group 1 signs of depression were detected significantly more of-
ten than in group 2. At the same time, moderate depression prevailed in them (p < 0.05) 
(Table 2).
Correlation analysis of the Beck Depression Scale and VAS Scale indicators revealed a 
moderately strong relationship (r = 0.66, p <0.05), indicating a direct relationship between 
the severity of pain syndrome and the severity of depression (Fig. 3).
The studies also showed that patients of group 1  were significantly more likely to 
have cephalgia syndrome than in the control group (Table 3). Despite the predominance 
of tension headache in patients of group 1, significant differences with the control group 
were obtained in terms of the proportion of patients with hypertensive headache (Table 3).
Fig. 2. Distribution density of patients with connective tissue dysplasia phe-
notype depending on the prevalence of pathological changes in the spine and 
indicators of pain severity in the spine
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Table 2. Psychopathological disorders in the examined patients
1 group (n=28) 2 group (n=33) P 1–2
Psychopathological disorders (total) 28 (100 %) 21 (63.6 %) p < 0.05
Of them:
Asthenic syndrome 24 (85.7 %) 16 (76.2 %) p > 0.05
Obsessive-compulsive disorder 6 (21.4 %) 2 (9.5 %) p > 0.05
Anxiety-phobic disorder 15 (53.6 %) 8 (38.1 %) p > 0.05
Moderate depression 6 (21.4 %) 1 (4.8 %) p > 0.05
Mild depression 11 (39.3 %) 2 (9.5 %) p < 0.05
Minimal depression 6 (21.4 %) 11 (52.4 %) p < 0.05
Note: p — significance of differences between groups; Group 1 — patients with connective tissue dys-
plasia phenotype; 2 — control group
Fig. 3. Graph of the correlation between the VAS scores and the Becks Depression 
Scale
Note: BDI — Beck Depression Inventory; VAS — Visual Analogue Scale.
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Table 3. Distribution of patients depending on the presence and signs of cephalgia syndrome
Signs 1 group (n = 28) 2 group (n = 33) Р 1–2






Localization (area) Frontotemporal 10 (47.6 %) 0 (0 %) -
Parieto-occipital 2 (9.5 %) 2 (25 %) p<0.05
Diffuse 9 (42.8 %) 6 (75 %) p>0.05
Type Tension headache 11 (52.3 %) 6 (75 %) p>0.05
Migraine 3 (14.3 %) 1 (12.5 %) p>0.05
Hypertensive 7 (33.3 %) 1 (12.5 %) p<0.05
Note: p — significance of differences between groups; 1 group — patients with connective tissue dys-
plasia phenotype; 2 group — control group
Cephalgia syndrome was more often observed in patients with mild CNS pathology 
detected during neuroimaging. According to MRI / CT of the head, changes in the central 
nervous system in group 1 were represented by arachnoid cysts, external-internal and ex-
ternal hydrocephalus, foci of gliosis in 85.7 % of cases. The openness of the circle of Willis 
was found in 42.8 %. In the same part of the patients of the main group, according to the 
data of ultrasound diagnostics, signs of venous dysgemia were determined.
In 18 (64.3 %) patients of group 1, according to anamnesis, perinatal pathology of the 
central nervous system was found, in group 2 it was detected only in 2 (6.1 %) patients 
(p < 0.05).
Neurological deficit due to organic CNS pathology was manifested by signs of pyram-
idal insufficiency, cranial nerve dysfunction, vestibulocerebellar insufficiency, and cogni-
tive disorders predominantly in group 1  patients. Peripheral nervous system disorders 
were characterized by radicular syndromes (p < 0.05) (Fig. 4).
Almost obligate manifestations of CNS lesions were autonomic disorders, which were 
more often detected in patients of the main group (24 / 85.7 % and 6 / 18.1 %, p < 0.05). 
Disorders of the autonomic nervous system (ANS) were presented in the form of lipoti- 
mia, accompanied by a feeling of lightheadedness, nausea, weakness, sweating; orthostatic 
disorders that arose when the body position changed from horizontal to vertical with 
darkening in the eyes and tachycardia; hyperhidrosis; panic attacks. In patients with CTD, 
orthostatic disorders (15 / 62.5 %) and lipotimia (9 / 37.5 %) dominated. Panic attacks oc-
curred in 12.5 % of cases.
Analysis of the Kerdo index indices, which makes it possible to assess the direction 
of autonomic shifts mainly in cardiovascular system revealed the presence of sympa-
thicotonia and parasympathicotonia in both groups. The comparison of Kerdo index in 
subgroups with sympathicotonia and parasympathicotonia in the 1st and 2nd groups re-
vealed statistically significant differences between them (p<0.05), Table 4. In group 1, both 
sympathicotonia and parasympathicotonia indexes had more pronounced values than in 
group 2 (Table 4).
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Table 4. Values of the Kerdo index in the examined patients
Group Positive Kerdo index (predominance of sympathetic reactions)
Negative Kerdo index 

















Р 1–2 <0.05 <0.05
Note: p — significance of differences between groups; Group 1 — patients with connective tissue dys-
plasia phenotype; 2 — control group
In the structure of somatic disorders in patients with a dysplastic phenotype, inflamma-
tory diseases of the ENT organs and the bronchopulmonary system (67.8 %), pathology of 
the heart and cardiac activity (57.1 %) as well as dysfunction of the digestive system (42.8  %).
Patients of the main group who had a history of diseases of the ENT organs and the 
bronchopulmonary system rated the severity of pain syndrome higher on the VAS scale 
than patients without them (p < 0.05) (Fig. 5).
Discussion
Our investigation showed that patients with vertebrogenic syndrome and CTD phe-
notype revealed scoliotic, kyphoscoliotic spinal deformities, functional instability, and 
vertebral retrolisthesis due to connective tissue insufficiency significantly more frequently 
than the control group according to clinical data and neuroimaging. This is consistent 
with the data of numerous researches [6; 9; 14–16]. These patients were characterized by a 
Fig. 4. Neurological status of group 1 and 2 patients
Note: * — significance of differences between groups when p < 0.05; PI — pyramidal 
insufficiency; VCI — vestibulocerebellar insufficiency; RS — radicular syndromes; DCN — 
dysfunction of cranial nerves; CD — cognitive disorders.
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more intense pain syndrome associated with the involvement of more spinal structures in 
the pathological process. The duration of pain syndrome in them was significantly longer 
than in the control group. Prolonged or frequently repeated pain impulses due to peri- 
pheral irritation of nociceptors of the osteoarticular system can lead to increased activa-
tion of central neurons in the dorsal horns of the spinal cord  — central sensitization. 
On the other hand, impaired neurotransmitter transmission, for example, in depression, 
which occurred in the structure of psychopathological disorders in patients with CTD, 
can be a predisposing factor in the development of dysfunction of the antinociceptive 
system — central desensitization. Central sensitization and disinhibition lead to the de-
velopment of hypersensitivity in relation to pain stimuli and, as a consequence, to a higher 
assessment of pain syndrome intensity [17; 18], which we observed in patients with CTD. 
In addition, impaired magnesium-calcium or serotonin metabolism, which affects the 
functioning of the antinociceptive system, is quite common in these patients [6].
It is known that chronic pain syndromes can be accompanied by the formation of 
pathological integrations in the CNS, such as generators of pathologically increased 
excitation and pathological algic system involving different structures of the brain and 
spinal cord [19]. Pathological system formation is possible when the nervous system 
is damaged and CNS integrative control is impaired [19]. Pathological systems are not 
only the basis of developing neuropathological syndromes but can also suppress physio- 
logical systems and their antisystems, contributing to the development of pathological 
processes. In this connection, it can be supposed that the formation of pathological inte-
Fig. 5. Distribution density of patients with the phenotype of connective tissue 
dysplasia, depending on the presence of diseases of the ENT organs and the broncho-
pulmonary system in the anamnesis and indicators of the severity of pain in the spine.
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grations occurs faster and they are more stable on the background of structural changes 
in the brain tissue. In 85.7 % of the examined patients of the main group, mild structural 
changes of the brain tissue were detected, which could be one of the risk factors for 
the development of neuropathological syndromes — cephalgia, autonomic dysfunction, 
psychopathological and somatic disorders. Patients with CTD had significantly more 
frequent neurological deficit in the form of pyramidal, cerebellar, mild extrapyrami-
dal insufficiency and cognitive disorders, disorders of oculomotor and trigeminal facial 
nerve functions. They were significantly more likely to have a history of perinatal CNS 
pathology (PPCNS) compared to the control group (p<0.05). Therefore, we cannot ex-
clude the influence of epigenetic factors and deny the hypothesis that PPCNS may be a 
risk factor for connective tissue dysplasia, and the latter may lead to decompensation of 
neurological pathology [20; 21].
Cephalgia syndrome in patients with CTD manifested predominantly tension head-
ache (52.3 %) and hypertensive cephalgia (33.3 %), in contrast to that indicated in the 
literature as the most frequent migrainous headache [6]. Migrainous type of headache was 
determined in 14.3 % of cases. Among the factors responsible for cephalgia syndrome, a 
significant role belongs to vertebrogenic pathology (including craniovertebral anomalies), 
angiodystonia of cerebral vessels, often with the phenomena of venous insufficiency and 
hydrocephaly.
Autonomic disorders are almost obligatory disorders in patients with the CTD phe-
notype, occurring in the undifferentiated form of CTD in 78 % of cases [6]. In our studies, 
they were found in 85.7 % of patients. Among autonomic symptoms, orthostatic distur-
bances dominated (62.5 %), accompanied by darkening of eyes, tachycardia, and light diz-
ziness when moving from horizontal to vertical position. Analysis of the data obtained by 
Kerdo index calculation in the patients revealed significant shifts towards sympathicoto-
nia (46.4 %), and vagotonia (53.6 %). They were significantly higher in patients with CTD 
phenotype, indicating more pronounced tension of different parts of autonomic nervous 
system in patients of this group. Patients with CTD are considered to be more susceptible 
to the development of psychoemotional disorders [6; 22; 23]. In our study, we showed that 
Beck Depression Scale signs of depression in patients with the dysplastic phenotype were 
revealed more frequently than in the control group. Moderate depression was predomi-
nant (39.3 %). Correlation analysis revealed a moderate reliable relationship between the 
severity of vertebrogenic pain syndrome and the level of depression, which suggests the 
role of the psychoemotional factor in the formation of pain in vertebrogenic pathology in 
this group of patients.
Somatic diseases detected in patients of the main group correspond to the struc-
ture of pathologies associated with connective tissue dysplasia [4; 6]. Polyorganic lesions 
in CTD are caused by a wide representation of its components in the body [24]. In our 
study, a large proportion were inflammatory diseases of ENT organs and bronchopul-
monary system (67.8 %), heart and cardiac pathology (57.1 %), and digestive system dis-
eases (42.8 %). Diseases of ENT organs and bronchopulmonary system with a tendency to 
chronization are associated with immune system disorders. However, the mechanisms of 
immune disorders in CTD are still almost unstudied, and the available data are contradic-
tory. The presence of immune disorders accompanying bronchopulmonary and visceral 
CTD syndromes increases the risk of associated pathology of the corresponding organs 
and systems [6]. This makes it necessary to do more research in this direction.
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Conclusion
The studies allowed us to specify that vertebrogenic pain syndrome in young pa-
tients with the phenotype of undifferentiated CTD occurs on the background of struc-
tural changes of the spinal column and comorbid pathologies — neurological deficit with 
vegetative lability and psychopathological disorders, cephalgia, somatic dysfunction with 
the predominance of disorders of the bronchopulmonary system and ENT organs. The 
correlation between the severity of pain syndrome and depressive disorders as well as 
its dependence on the prevalence of pathological changes in the spine, its prevalence in 
persons with greater somatic and cerebral aggravation allows taking these factors into ac-
count when we speak about the formation of pain syndrome mechanisms in patients with 
vertebrogenic pathology and connective tissue dysplasia.
A comprehensive investigation of the signs of connective tissue dysplasia in young 
adults with vertebrogenic pathology will allow predicting the progression of pain syn-
drome and determines the necessity of a multidisciplinary approach to minimize the in-
fluence of comorbid disorders on the course of pain syndrome.
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